PATENT CLAIM ANALYSIS

Application Number: 15749485
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "357000"]

Abstract:
The present invention relates to a composition for use in treating a glioma or ameliorating the effects of a glioma, particularly glioblastoma, wherein said composition comprises a first active agent selected from the group consisting of a compound of formula (I), or a pharmaceutically acceptable salt thereof, (I) and a second active agent, which is temozolomide, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.

Claim (Index 11):
The method according to  claim 10  where said first active agent is in an oral dosage form and said second active agent is in an oral or an intravenous dosage form.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 86.0
- Lexical Diversity: 1.68085
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15316797', '14246558', '12878113', '13353713', '15467613']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7826007271935624
- 35 USC 102 Novelty (BERT): 0.5444750802051078
- Combined Prediction Score: 0.758788162494717
- Mean Citation Score: 278.55366200000003
- Max Citation Score: 398.48172
- Similarity Product: 282.5654334612608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test